---
title: "Hong Kong's ECM Financing Reaches Highest Level Since 2021"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/281493958.md"
description: "Hong Kong's equity capital market (ECM) financing has reached its highest level since 2021, totaling $21.16 billion as of March's end. This represents a 26% increase from the previous year, with ECM issuances rising by 66% year-on-year, according to data from the London Stock Exchange Group's Deals Intelligence team."
datetime: "2026-04-02T08:45:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281493958.md)
  - [en](https://longbridge.com/en/news/281493958.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281493958.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/281493958.md) | [English](https://longbridge.com/en/news/281493958.md)


# Hong Kong's ECM Financing Reaches Highest Level Since 2021

Hong Kong's equity capital market (ECM) financing has reached its highest level since 2021, according to data released by the London Stock Exchange Group's (LSEG) Deals Intelligence team. As of the end of March, ECM financing in Hong Kong totaled $21.16 billion, marking a 26% increase compared to the previous year. Additionally, the number of ECM issuances rose by 66% year-on-year.

### 相關股票

- [CSOP HSI ETF (03037.HK)](https://longbridge.com/zh-HK/quote/03037.HK.md)
- [TRACKER FUND (02800.HK)](https://longbridge.com/zh-HK/quote/02800.HK.md)
- [ChinaAMC Hang Seng ETF (159920.CN)](https://longbridge.com/zh-HK/quote/159920.CN.md)
- [ISHARESHSI (03115.HK)](https://longbridge.com/zh-HK/quote/03115.HK.md)
- [Hang Seng Index (00HSI.HK)](https://longbridge.com/zh-HK/quote/00HSI.HK.md)

## 相關資訊與研究

- [Hong Kong retail sales jump nearly 12% in first 2 months of year](https://longbridge.com/zh-HK/news/281346585.md)
- [Guangdong-HKGBA Returns to Profitability in 2025](https://longbridge.com/zh-HK/news/281116626.md)
- [Scryb Reports 2026 AGM Results and Welcomes Veteran Capital Markets and Finance Directors | SCYRF Stock News](https://longbridge.com/zh-HK/news/281354744.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-HK/news/281325910.md)
- [China Minsheng (OTCMKTS:CMAKY) Issues Quarterly Earnings Results](https://longbridge.com/zh-HK/news/281388711.md)